Recovery Plus 1St Print 2016.Indd

Total Page:16

File Type:pdf, Size:1020Kb

Recovery Plus 1St Print 2016.Indd Recovery Plus How to help addicts into long-term enriched recovery SSaveave ttime,ime, ssaveave liveslives RECOVERY FROM ADDICTION IS POSSIBLE: Experience, research and hope, by the experts MUTUAL AID: RESEARCH ON EFFECTIVENESS by Professor John Kelly HOW TO MEASURE RECOVERY: by Professor Joanne Neale WHAT IS ADDICTION? 15 MANIFESTATIONS and 12 core characteristics, by Mandy Saligari HELP THE CHILDREN OF ALCOHOLICS Politician Liam Byrne’s campaign THE COMPLEX PATIENT: Integrated treatment, by Dr Michael Genovese WOMEN’S ISSUES, MEN’S ISSUES: Similarities and diff erences, by Paul Hokemeyer ADOLESCENTS: PREVENTION & TREATMENT by Dr Andrea Grubb-Barthwell, Mary Brett REDUCING STIGMA EASES PATH TO CARE: Recovery Brands’ £7,000/$10,000 prize to help FAMILY MATTERS: SUPPORT & BE SUPPORTED by Don Lavender ADVANCES IN DRUG AND ALCOHOL TESTING: Innovation, technology – and integrity SPOT THE 7 SIGNS OF RELAPSE ... use them to help change, by David Brown STRUCTURED FAMILY INTERVENTIONS History and overview by Rebecca Flood PLUS: Where to fi nd rehabs and self-help groups... alphamusic... Laura Loves, Laura Loathes... and 12-page Recovery Plus pullout programme. your library’s essential reference February Feb 2016 2016 1 Recovery Plus Recovery Plus SSaveave ttime,ime, ssaveave liveslives Welcome to Recovery Plus, will do the same. That’s the our fi rst annual publication philosophy of the experts in this dedicated to the professional publication and the publishers. knowledge of how to recover People are what matter in this from addictive behaviours. world – not money nor fame nor Worldclass experts have written buildings nor organisations nor articles on their specialist topics to institutions. Only people, values give you a comprehensive overview and ethics. Achievement comes to or ‘crash course’ on addiction and people who can do great things for recovery. We hold them in such high themselves. Success comes when they regard that they were invited them to lead followers to do great things for speak at our conferences – and they generously them. But a legacy is created only when leaders off er you their PowerPoint presentations, too. All enable their people to do great things without you need do is access our accompanying online them – hard as that might sound to you initially. Recovery Plus journal, then click on the “Click for presentation” icon embedded in their articles. This applies not only to staff and colleagues: it is Professor John Kelly’s article, for instance, stands also the most eff ective way to give healthy life alone but also links to 70 pages of select research. choices to people with dependencies. And so Download them from www.dbrecoveryresources.com. we hope to help you to help others. We hope to help you... Gain confi dence in handling clients What should be the legacy of a successful leader? with complex needs… Prevent relapse... Break And how is that relevant to this publication? destructive intergenerational patterns... Know 20 years from now, all that will matter is the when to refer and who you can safely refer to… people you connected with in such a way that Discover new colleagues... and fi nd sources of you added value and meaning to their lives. The help from our Directories of mutual-aid groups fi nal test of a leader is that s/he leaves behind in and treatment centres towards the back of this others the conviction and will to carry on. That publication. Click on the photos in our online requires imparting expertise as well as passion, journal to be brought directly to their websites. and helping people to connect with others. The greatest legacy a leader can leave is having In the course of your work, as you increasingly helped to develop other leaders. Develop them encounter people/colleagues with alcohol or as widely and as deeply as you can, supported by drug problems or addictive behaviours, you can the knowledge and contacts in Recovery Plus. grow confi dent that you are doing the best for them – and yourself, following best practice. If If you want to leave a legacy, invest in people, you need more support, do join the next intense and encourage those you develop to pass on fully-rounded ‘crash course’ in how to recover everything they learn from you to others who from addiction, on 20 May: see page 35. 2 Feb 2016 your library’s essential reference Feb 2016 3 Recovery Plus Recovery Plus In our online ‘sister’ Recovery Plus journal, you can click on the orange button beside each article to be automatically brought to it. Contents FOR YOUR DIARY: DRUG AND ALCOHOL POLICY IN 2016 3 WELCOME TO THE FIRST RECOVERY PLUS ESSENTIAL REFERENCE 47 Recovery Plus What should be the legacy of a successful leader? Creating more leaders – like you. Will there be an open consultation? What will policy include? Laura Graham investigates. conference NEWS FAMILY MATTERS: THROWING A LIFELINE 7 48 20 May 2016 Catch up on the addiction field: latest legislation, rehab closures – and hope, psychoactive Don Lavender explains the importance of family behaviours when addicts return after rehab. Interventions Plus substances, dependency on prescribed medicines, legalisation lobbying and more... HELP PARENTS TO HELP THE NEXT GENERATION, part 1 tutorials, training 50 MEASURING RECOVERY: MOVING TO AGREEMENT The later a person starts to use substances, the better their life chances, urges Dr Andrea Barthwell. 12 21 May 2016 To optimise treatment and recovery, service providers’ and users’ definitions of addiction Waldorf Hilton, recovery must converge more – Dr Joanne Neale and colleagues start the research. 52 PREVENTION: SUFFER THE CHILDREN, part 2 London. How cannabis affects children is often misinterpreted and denied; Mary Brett lists the facts. SCIENTIFICALLY-INFORMED RECOVERY: WHAT’S NEW? 16 Harvard’s first professor of addiction medicine, John Kelly, summarises rigorous studies by 56 THE SEVEN WARNING SIGNS OF RELAPSE IC&RC CEUs and the scientific community on the clinical utility and cost offsets of mutual-help groups. Relapse back into addiction is not an overnight event – it is weeks or months in the making. CIPs awarded. David Brown identifies seven warning signs so that disaster can be prevented. MEN AND WOMEN IN TREATMENT: THE ISSUES 20 For men and women in active addiction, or accessing treatment, or in recovery, what are the INTERVENTIONS: THE HISTORICAL PERSPECTIVE 62 similarities and differences? Paul Hokemeyer did the research for you and gives his findings. Over 90% of structured interventions can be successful in persuading a reluctant addict into treatment - they also create a shield for troubled family members. Rebecca Flood explains. ADDICTION COMES IN PEOPLE, NOT PACKAGES 26 “It is not only possible to get completely well from addiction – I would also claim that it is BRAINWAVES, MUSIC, ADDICTION, TRAUMA possible to prevent it,” says Mandy Saligari, who has ‘manualised’ how to achieve this. 66 How can music actively assist in the treatment of addiction and trauma? John Levine explains. INTEGRATE TREATMENT FOR COMPLEX PATIENTS STIGMA AS BARRIER TO RECOVERY – PLUS £7,000/$10,000 COMPETITION 28 70 Integrative treatment includes all viable modalities. While we cannot cure dual diagnosis, Recovery Brands is campaigning to reduce the stigma of addiction treatment and recovery. IM can help to heal, maintaining hope and positive growth. Dr Michael Genovese explains. 72 HOW TO FIND: SELF HELP GROUPS LATEST ADVANCES IN DRUG AND ALCOHOL TESTING How to contact the mutual-aid groups recommended by WHO and NICE. 30 George Powell explains how innovation and technology have impacted the rehab sector. 76 LAURA LOVES, LAURA LOATHES HELP THE CHILDREN OF ALCOHOLICS: A POLITICIAN’S CAMPAIGN Despite a “dismal year for recovery” in 2015, Laura Graham fi nds reasons to be optimistic. 34 MP Liam Byrne recently opened up publicly about his experience as the child of an alcoholic – and is proposing legislation for all local authoriites to recognise and support them. 78 HOW TO FIND: PROFESSIONAL CARE If you or a loved one want the best of treatment for an addiction problem, fi nd it here. FREE 12-PAGE PULLOUT PROGRAMME: RECOVERY PLUS CONFERENCE WHAT IS... A CIP? EXPLAINING CERTIFIED INTERVENTION PROFESSIONALS 35 82 Join our team and a host of professionals and trainees in London on 20 and 21 May! Credentialling gives you an ‘edge’ over lesser-qualifi ed counterparts. 4 Feb 2016 your library’s essential reference Feb 2016 5 Recovery Plus Recovery Plus Celebrate recovery: News: stories symbolising trends to watch This year’s challenges Catch up with the addiction fi eld! Each of the news invest in recovery items below crystallises a major nuance in the drug and alcohol prevention and treatment fi eld: challenges we will be facing in 2016 and for years to come. PRESCRIBED DRUGS associated with dependence and withdrawal – building a consensus for action... was published by the British Medical Association last October. Read CEP summary and link to the 44-page report at http://cepuk.org/2015/10/13/cep-welcomes-report- This year celebrates the millions of people who have recovered from addiction bma-prescribed-drug-dependence. Campaigners have been – and the work of the caring professionals who reach out daily to help the many, fi ghting for recognition for over 30 years. 5-year drug strategy many millions of vulnerable people and suff ering families who still need to E-CIGARETTES... with opinion still sharply divided as comes out in March experience enriched recovery. to whether e-cigarettes help stop tobacco smoking or We celebrate, encourage and advance that by introducing Recovery Plus as the instead cause harm, the NHS spends taxpayer money “With deaths from illegal drugs in England and Wales at the highest rate ever recorded, we might imagine UK’s major print-and-posted journal on how to recover from addiction, as well prescribing them: see overview at www.telegraph.co.uk/ that the Home Offi ce would be desperate for a as being available fully interactive online (with over 2million views in 2015).
Recommended publications
  • NHS Fife Guidelines for Benzodiazepine Prescribing in Benzodiazepine Dependence
    NHS Fife Guidelines for Benzodiazepine Prescribing in Benzodiazepine Dependence Dr. A. Baldacchino, Liz. Hutchings, Addiction Services Issued: April 2013 Review Date: April 2016 1 Approved by NHS Fife ADTC on behalf of NHS Fife Date June 2013 Contents Flowchart for Benzodiazepine Withdrawal ……………………………………………………………3 Establishing type of dependence. ........................................................................................... 4 Assessment of Benzodiazepine Dependence .............................................................................. 5 Management of dependence in therapeutic dose users ........................................................... 6 Management of dependence in prescribed high dose users. ................................................... 7 Management of dependence in illicit and recreational users. .................................................. 8 Psychological support. ................................................................................................................. 9 Pharmacological support............................................................................................................ 10 Appendices Appendix 1 Example Patient Letter (regular user) ................................................. 11 Appendix 2 Information leaflets and advice from the internet ................................ 13 Appendix 3 DRUG DIARY ..................................................................................... 14 Appendix 4 Benzodiazepine conversion table ......................................................
    [Show full text]
  • The Diagnosis and Management of Benzodiazepine Dependence Heather Ashton
    The diagnosis and management of benzodiazepine dependence Heather Ashton Purpose of review Abbreviation Despite repeated recommendations to limit GABA g -aminobutyric acid benzodiazepines to short-term use (2–4 weeks), doctors worldwide are still prescribing them for months or years. # 2005 Lippincott Williams & Wilkins This over-prescribing has resulted in large populations of 0951-7367 long-term users who have become dependent on benzodiazepines and has also led to leakage of benzodiazepines into the illicit drug market. This review Introduction outlines the risks of long-term benzodiazepine use, gives Since their introduction in the 1950s, benzodiazepines guidelines on the management of benzodiazepine appear to have passed their zenith of medical popularity. withdrawal and suggests ways in which dependence can However, they are still prescribed excessively and often be prevented. inappropriately. With their reputation perhaps approach- Recent findings ing a nadir, at least as prescribed medications for Recent literature shows that benzodiazepines have all the long-term use, it is timely to review approaches to the characteristics of drugs of dependence and that they are diagnosis and management of dependence on these inappropriately prescribed for many patients, including drugs. those with physical and psychiatric problems, elderly residents of care homes and those with comorbid alcohol The benzodiazepine bonanza and substance abuse. Many trials have investigated In the late 1970s benzodiazepines became the most methods of benzodiazepine
    [Show full text]
  • The BENZODIAZEPINE TOOLKIT
    the BENZODIAZEPINE TOOLKIT By Reconnexion Acknowledgements The 2018 edition of the Beyond Benzodiazepines toolkit has been revised from the 1997 original updated in 2000 and again in 2010. For this version thanks to Erin Oldenhof, James Szeto and Jane Anderson-Wurf. The 2010 version was updated by Tomi Redman and Gwenda Cannard with additional material by Janet Haynes, Jo Marston and Laurence Hennessey. Reconnexion (now a service of EACH) is grateful for the support of ExxonMobil Australia for enabling the revision and update on the 2010 manual. The 1997 original manual was written by Elin Ree and supported by ExxonMobil for which Reconnexion is grateful. Thanks to the Psychotropic Expert Group, Therapeutic Guidelines Limited for permission to use the Comparative Information for Benzodiazepines, Zolpidem and Zopiclone table in Chapter Four. Updates, revisions and feedback retained in the revised version were provided by Therese Barry (Alcohol & Drug Counsellor, Western Region Community Health Centre), Dr Robert Cummins (Deakin University), Hilde Edward (Swinburne University), Lisa Frank (University of Melbourne), Melanie Hands (Project Manager, Drug & Alcohol Clinical Advisory Service, Turning Point Alcohol & Drug Centre), Terrie Hollingsworth (Counsellor, Sunbury Community Health), Dr Peter Johnson (GP), Dr Len Klimans (Chemical Dependency Unit, Royal Women’s Hospital), Dr Nic Lintzeris (Turning Point Alcohol & Drug Centre), Dr Mike McDonough (Consultant, St. Vincent’s Alcohol & Drug Program, Western General Hospital Alcohol & Drug Program), Peter McManus (Secretary, Drug Utilisation Sub Committee, Pharmaceutical Benefits Scheme, Department of Health & Ageing), Dr Robert Moulds (Director, Department of Clinical Pharmacology & Therapeutics, Royal Melbourne Hospital), Jackie Shaw (Manager, Depaul House, St Vincent’s Hospital, Melbourne), Lyn Walker (Manager, CASA House, Royal Women’s Hospital, Melbourne) and Dr Sally Wilkins (North East Melbourne Psychiatric Services, Department of Human Services, Victoria).
    [Show full text]
  • Social Networking and Benzodiazepine Withdrawal: The
    Catherine M. Pittman, Ph.D. William Youngs, Ph.D. Elizabeth (Lisa) Karle, MLIS Saint Mary’s College Notre Dame, Indiana ADAA Conference April 5, 2013 No Disclosures. Thank you We would like to begin by expressing our thanks to all those who completed the survey and shared their experiences with us. We also owe a great debt to the founder of BenzoBuddies as well as a skilled technician assistant associated with the group. They provided invaluable advice and assistance, and without their help, the survey would not have been as valid or successful. Finally, we want to thank research assistant Carla Leal for her patient assistance in the creation and coding of the survey. Note: This survey was reviewed and approved by the Institutional Review Board at Saint Mary’s College. When individuals have difficulty with anxiety, what is the most typical response? Often they approach their family doctor, who attempts to treat the anxiety or refers them to a psychiatrist. In either case, it is very likely that a medical (psychopharmalogical) solution may be offered. The solution offered is often benzodiazepines. The United States has the highest rate of benzodiazepine prescription in the world (Rivas- Vazquez, 2003). If the person is prescribed benzodiazepines, short term relief is obtained, but tolerance develops and increasing dosages may be required. Dependence on benzodiazepines is very likely, and how do we help individuals facing benzodiazepine dependence? The truth is we don’t. And this is the reason that Social Networking is important to them.
    [Show full text]
  • Benzodiazepine Equivalence Table
    benzo.org.uk : Benzodiazepine Equivalence Table http://www.benzo.org.uk/bzequiv.htm « back exit frame back to frame www.benzo.org.uk » BENZODIAZEPINE EQUIVALENCE TABLE (Benzodiazepine Equivalency Table) Revised April 2007 This Benzodiazepine Equivalence Table is based on the extensive research and clinical experience of Professor C Heather Ashton , DM, FRCP, Emeritus Professor of Clinical Psychopharmacology at the University of Newcastle upon Tyne, England. Sources: NRHA Drug Newsletter , April 1985 and Benzodiazepines: How they Work & How to Withdraw (The Ashton Manual ), 2002. The approximate equivalent doses to 10mg diazepam (Valium) are given. For a discussion of half-lives and equivalencies see also the Benzo FAQ document . 2 Approximately Half-life (hrs) Market Benzodiazepines 1 [active Equivalent Aim4 metabolite] Oral dosages (mg) 3 Alprazolam 6-12 0.5 a (Xanax, Xanor, Tafil) Bromazepam 10-20 5-6 a (Lexotan, Lexomil) Chlordiazepoxide 5-30 [36-200] 25 a (Librium) Clobazam 12-60 20 a,e (Frisium) 5 Clonazepam 18-50 0.5 a,e (Klonopin, Rivotril) 5 Clorazepate [36-200] 15 a (Tranxene) Diazepam 20-100 [36-200] 10 a (Valium) Estazolam 10-24 1-2 h (ProSom, Nuctalon) Flunitrazepam 18-26 [36-200] 1 h (Rohypnol) Flurazepam [40-250] 15-30 h (Dalmane) Halazepam [30-100] 20 a (Paxipam) 1 sur 3 01/02/2010 18:46 benzo.org.uk : Benzodiazepine Equivalence Table http://www.benzo.org.uk/bzequiv.htm Ketazolam 30-100 [36-200] 15-30 a (Anxon) Loprazolam 6-12 1-2 h (Dormonoct) Lorazepam 10-20 1 a (Ativan, Temesta, Tavor) Lormetazepam 10-12 1-2 h (Noctamid) Medazepam 36-200 10 a (Nobrium) Nitrazepam 15-38 10 h (Mogadon) Nordazepam 36-200 10 a (Nordaz, Calmday) Oxazepam (Serax, Serenid, 4-15 20 a Serepax, Seresta) Prazepam [36-200] 10-20 a (Centrax, Lysanxia) Quazepam (Doral) 25-100 20 h Temazepam (Restoril, Normison, 8-22 20 h Euhypnos) Triazolam 2 0.5 h (Halcion) Non-benzodiazepines with similar effects 1, 6 Zaleplon 2 20 h (Sonata) Zolpidem (Ambien, Stilnoct, 2 20 h Stilnox) Zopiclone 5-6 15 h (Zimovane, Imovane) Eszopiclone 6 3 h (Lunesta) (9 in elderly) 1.
    [Show full text]
  • Pharmacology and Effects of Cannabis: a Brief Review
    BRITISH JOURNAL OF PSYCHIATRY $2001), 178, 101^106 Pharmacology and effects of cannabis: Health Organization, 1997; Solowij, 1998). This fact is important since the ef- abriefreview{{ fects of THC are dose-related and most of the research on cannabis was carried out in the 1970s using doses of 5±25 mg THC C. HEATHER ASHTON !World Health Organization, 1997). Gold !1991, p. 356) remarks: ``This single fact has made obsolete much of what we once knew about the risks and consequences of marijuana use''. In the UK at present, many recreational users grow their own supplies of high- Background Increasing prevalence of Herbal cannabis contains over 400 com- potency cannabis !exact details of how to recreational cannabis use among the pounds including over 60 cannabinoids, grow it can be obtained on the internet). which are aryl-substituted meroterpenes Another main source is imports from Holland young population has stimulated debate unique to the plant genus CannabisCannabis..The The !also high-potency) and home growers can ononthe the possible effects of acute andlong-and long- pharmacology of most of the cannabinoids obtain seeds in Amsterdam at £10±£50 term use.use.term is largely unknown but the most potent for 10 seeds, depending on potency. Canna- psychoactive agent, DD99-tetrahydrocannabi- bis can be smoked as joints, from pipes, or Aims TohighlightrecentknowledgeofTohighlightrecent knowledge of nol !nol!DD99-THC, or THC), has been isolated, from `buckets', by inhaling from a mass of mechanisms of action, effects on synthesised and much studied. Other plant plant or resin ignited in a sawn-off plastic psychomotor and cognitive performance, cannabinoids include DD88-THC, cannabinol bottle.
    [Show full text]
  • Perils in Benzodiazepine Withdrawal: Case Report
    EJMED, European Journal of Medical and Health Sciences Vol. 2, No. 3, June 2020 Perils in Benzodiazepine Withdrawal: Case Report V. F. H Macfarlane, L. J. Moore obstructive sleep apnea resolved on repeat testing after Abstract — The discovery that clonazepam prescribed for conversion to lorazepam. Lorazepam was substituted the treatment of migraines caused obstructive sleep apnea led because it is short acting with no active metabolites and is to a rapid taper of clonazepam and substitution of lorazepam. considered favorable for use in the elderly. A very rapid Lack of accurate knowledge about the different pharmacokinetics and actions of different benzodiazepines at conversion and an inadequate substitution were made and GABA-A receptors and the risks associated with rapid the patient developed multiple physical symptoms. It took benzodiazepine withdrawal resulted in the development of the more than four months before an addiction specialist benzodiazepine protracted withdrawal syndrome. Moderately instituted appropriate treatment with a low dose of diazepam severe disability continued after 2 years. Insufficient and recognised the symptoms were due to the knowledge about benzodiazepines and their withdrawal is a benzodiazepine protracted withdrawal syndrome. None of serious problem as doctors across the world are under extreme pressure to stop prescribing them but do not have an the patient’s previous doctors had any understanding of understanding of the potential perils involved. The benzodiazepine withdrawal or recognised the challenges pathophysiology of protracted withdrawal syndrome remains associated with conversion of one benzodiazepine for poorly understood and there is no recognised treatment. another. A very slow titration of 0.5 to 1 mg diazepam every Information about appropriate management of withdrawal 2-3 months was recommended by the addiction specialist; and the protracted withdrawal syndrome are available on however, a new treating doctor reduced the dose of Professor Ashton’s website at www.benzo.org.uk.
    [Show full text]
  • Step by Step Guide to Reducing from Benzodiazepines
    STEP BY STEP GUIDE Reducing from Benzodiazepines & Recovery from Withdrawal 1 Table of Contents Introduction ........................................................................................................ ...3 List of Benzodiazepines .......................................................................................... 5 Dose Equivalents .................................................................................................... 6 Stabilising and Reducing the Dose ......................................................................... 7 Example of a Reduction Regime .......................................................................... 11 Benzodiazepine Withdrawal Symptoms .............................................................. 13 Management of Withdrawal Symptoms .............................................................. 14 Tips to Help with Withdrawal Symptoms ............................................................ 15 Suggestions for your Diet whilst withdrawing ..................................................... 17 Staying off Tranquillisers and Sleeping Pills ......................................................... 18 Relaxation ............................................................................................................. 19 Breathing Exercise ................................................................................................ 22 Resources for Further Assistance ......................................................................... 23 2 Introduction These
    [Show full text]
  • Risks of Dependence on Benzodiazepine Drugs: a Major Problem of Long Term Treatment
    Risks of dependence on benzodiazepine drugs: a major problem of long term treatment Heather Ashton BMJ: first published as 10.1136/bmj.298.6666.103 on 14 January 1989. Downloaded from Phlegmatic people dislike taking benzodiazepine drugs. In those with low'anxiety traits benzodiazepines Profiles of dependence on drugs are dysphoric and may paradoxically increase anxiety.' In normal subjects benzodiazepines improve perform- People who become dependent on drugs are suggested ance under experimental stress but worsen it under to be two different populations at the extremes of a conditions of low stress.2 Benzodiazepines relieve pre- normal distribution. Those who take drugs for pro- operative anxiety in patients with high anticipatory tection are anxious, have high scores for neuroticism but not in those with low anxiety.3 (N),46 17 are highly susceptible to punishment,'4 tender anxiety anticipatory minded, and socially compliant.4 Their preferred Thus like 0i receptor blocking agents benzodiazepines drugs are benzodiazepine tranquillosedatives, which require some underlying tone upon which to exert their they tend to take long term in low, prescribed doses. anxiolytic effects. In general, the greater the anxiety They are sensitive to withdrawal largely because of the greater the anxiolytic efficacy. their anxiety and poor abilities in coping with stress. It follows that most people who take benzodiazepines In contrast, those who take drugs for kicks have are anxious. In students a history of prescribed high scores for psychoticism (P),'7 are highly sensitive benzodiazepines correlates with a high anxiety trait.4 to reward,'4 impulsive, tough minded, antisocial, and Long term users likewise have high scores for neuroti- seek sensation.4 '7 They tend to abuse hard and soft cism.
    [Show full text]
  • Fife Guidelines for Benzodiazepine Prescribing in Benzodiazepine Dependence
    NHS Fife Guidelines for Benzodiazepine Prescribing in Benzodiazepine Dependence Dr. A. Baldacchino, Liz. Hutchings, Addiction Services Issued: April 2013 Review Date: April 2016 1 Approved by NHS Fife ADTC on behalf of NHS Fife Date June 2013 Contents Flowchart for Benzodiazepine Withdrawal ……………………………………………………………3 Establishing type of dependence. ...........................................................................................4 Assessment of Benzodiazepine Dependence..............................................................................5 Management of dependence in therapeutic dose users............................................................6 Management of dependence in prescribed high dose users. ...................................................7 Management of dependence in illicit and recreational users. ..................................................8 Psychological support. .................................................................................................................9 Pharmacological support............................................................................................................10 Appendices Appendix 1 Example Patient Letter (regular user).................................................11 Appendix 2 Information leaflets and advice from the internet................................13 Appendix 3 DRUG DIARY.....................................................................................14 Appendix 4 Benzodiazepine conversion table.......................................................15
    [Show full text]
  • Ashton-Manual.Pdf
    ! With full permission from relevant parties, Benzodiazepine Information Coalition (BIC) is offering this reprint of Dr. Heather Ashton’s benzodiazepine guide, aka the “Ashton Manual,” in PDF format solely for ease of printing, sharing, and accessibility by professionals and patients alike. With the exception of the updated contact and support list, this copy is identical to the original, completely unchanged and unedited, including the original medical disclaimer provided by benzo.org.uk where the manual was first published. BIC provides this copy solely for educational purposes and as a courtesy, bearing no responsibility for the contents of the manual or the outcomes of following it. www.benzoinfo.com Any use of materials contained within this manual including reproduction, modification, or republication without the prior permission of Professor C Heather Ashton is strictly prohibited. © Copyright Professor C Heather Ashton To purchase a bound copy of the manual please visit www.benzobookreview.com BENZODIAZEPINES: HOW THEY WORK AND HOW TO WITHDRAW (aka The Ashton Manual) • PROTOCOL FOR THE TREATMENT OF BENZODIAZEPINE WITHDRAWAL • Medical research information from a benzodiazepine withdrawal clinic Professor C Heather Ashton DM, FRCP Revised August 2002 • Ashton Manual Index Page • Contents Page • Introduction • Chapter I: The benzodiazepines: what they do in the body • Chapter II: How to withdraw from benzodiazepines after long-term use • Chapter II: Slow withdrawal schedules • Chapter III: Benzodiazepine withdrawal symptoms, acute & protracted CONTENTS PAGE THE ASHTON MANUAL SUPPLEMENT, APRIL 2011 IMPORTANT MESSAGE FROM PROFESSOR ASHTON, JANUARY 2007 FOREWORD TO REVISED EDITION, AUGUST 2002 FOREWORD 2001 ABOUT PROFESSOR C HEATHER ASHTON, DM, FRCP SUMMARY OF CONTENTS MEDICAL DISCLAIMER CHAPTER I.
    [Show full text]
  • Risks of Dependence on Benzodiazepine Drugs: a Major Problem of Long Term Treatment
    Risks of dependence on benzodiazepine drugs: a major problem of long term treatment Heather Ashton BMJ: first published as 10.1136/bmj.298.6666.103 on 14 January 1989. Downloaded from Phlegmatic people dislike taking benzodiazepine drugs. In those with low'anxiety traits benzodiazepines Profiles of dependence on drugs are dysphoric and may paradoxically increase anxiety.' In normal subjects benzodiazepines improve perform- People who become dependent on drugs are suggested ance under experimental stress but worsen it under to be two different populations at the extremes of a conditions of low stress.2 Benzodiazepines relieve pre- normal distribution. Those who take drugs for pro- operative anxiety in patients with high anticipatory tection are anxious, have high scores for neuroticism but not in those with low anxiety.3 (N),46 17 are highly susceptible to punishment,'4 tender anxiety anticipatory minded, and socially compliant.4 Their preferred Thus like 0i receptor blocking agents benzodiazepines drugs are benzodiazepine tranquillosedatives, which require some underlying tone upon which to exert their they tend to take long term in low, prescribed doses. anxiolytic effects. In general, the greater the anxiety They are sensitive to withdrawal largely because of the greater the anxiolytic efficacy. their anxiety and poor abilities in coping with stress. It follows that most people who take benzodiazepines In contrast, those who take drugs for kicks have are anxious. In students a history of prescribed high scores for psychoticism (P),'7 are highly sensitive benzodiazepines correlates with a high anxiety trait.4 to reward,'4 impulsive, tough minded, antisocial, and Long term users likewise have high scores for neuroti- seek sensation.4 '7 They tend to abuse hard and soft cism.
    [Show full text]